Seeing Is Believing

Currently out of the existing stock ratings of Matthew Sheerin, 125 are a BUY (52.3%), 114 are a HOLD (47.7%).
Analyst Matthew Sheerin, currently employed at STIFEL, carries an average stock price target met ratio of 87.94% that have a potential upside of 20.96% achieved within 252 days.
Matthew Sheerin’s has documented 476 price targets and ratings displayed on 25 stocks. The coverage is on Technology, Healthcare sectors.
Most recent stock forecast was given on PRVA, Privia Health Group at 10-Apr-2025.
Analyst best performing recommendations are on CLS (CELESTICA).
The best stock recommendation documented was for SONO (SONOS) at 8/27/2018. The price target of $20 was fulfilled within 1 day with a profit of $1.08 (5.71%) receiving and performance score of 57.08.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 03-Feb-2023
$148
$8.37 (5.99%)
$120
1 months 28 days ago
(06-Feb-2026)
18/19 (94.74%)
$-10.6 (-6.68%)
150
Sell Since 16-Sep-2022
$115
$-24.63 (-17.64%)
$98
1 months 28 days ago
(06-Feb-2026)
8/10 (80%)
$-43.6 (-27.49%)
312
Sell Since 07-Feb-2025
$110
$-29.63 (-21.22%)
$99
9 months 25 days ago
(09-Jun-2025)
9/9 (100%)
$-13.28 (-10.77%)
322
Buy Since 03-Feb-2022
$135
$-4.63 (-3.32%)
$140
1 years 5 months 2 days ago
(01-Nov-2024)
5/5 (100%)
$13.97 (11.54%)
733
Hold Since 20-Sep-2016
$132
$-7.63 (-5.46%)
$132
1 years 10 months 6 days ago
(28-May-2024)
7/7 (100%)
$1.78 (1.37%)
79
What Year was the first public recommendation made by Matthew Sheerin?